Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
This Week on NeurologyLive® — July 22, 2024
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
NeurologyLive® Friday 5 — July 19, 2024
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the Second Half of 2024